In conclusion, the results demonstrated that ginsenoside Rg1 has a certain anti-AD activity whose possible mechanism may be related to suppressing the signaling transduction pathway of TLR3 and TLR4, and decreasing the inflammation factors induced by Aβ25–35 in NG108-15 cells. This evidence concerns the gene TLR4 and Alzheimer disease.